A detailed history of Fmr LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Fmr LLC holds 15,604 shares of RDY stock, worth $235,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,604
Previous 19,701 20.8%
Holding current value
$235,464
Previous $1.45 Million 17.79%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$68.26 - $76.19 $279,661 - $312,150
-4,097 Reduced 20.8%
15,604 $1.19 Million
Q1 2024

May 13, 2024

SELL
$67.36 - $77.59 $10,844 - $12,491
-161 Reduced 0.81%
19,701 $1.45 Million
Q4 2023

Feb 13, 2024

BUY
$64.27 - $69.9 $408,371 - $444,144
6,354 Added 47.04%
19,862 $1.38 Million
Q3 2023

Nov 13, 2023

SELL
$61.9 - $72.77 $13,803 - $16,227
-223 Reduced 1.62%
13,508 $903,000
Q2 2023

Aug 11, 2023

SELL
$53.34 - $63.11 $120,441 - $142,502
-2,258 Reduced 14.12%
13,731 $866,000
Q1 2023

May 11, 2023

BUY
$51.63 - $56.93 $242,402 - $267,286
4,695 Added 41.57%
15,989 $910,000
Q4 2022

Feb 13, 2023

BUY
$51.15 - $57.45 $151,864 - $170,569
2,969 Added 35.66%
11,294 $584,000
Q3 2022

Nov 10, 2022

SELL
$49.9 - $57.32 $27,445 - $31,526
-550 Reduced 6.2%
8,325 $436,000
Q2 2022

Aug 12, 2022

BUY
$49.62 - $58.13 $126,679 - $148,405
2,553 Added 40.38%
8,875 $492,000
Q1 2022

May 13, 2022

BUY
$48.27 - $65.25 $247,818 - $334,993
5,134 Added 432.15%
6,322 $352,000
Q4 2021

Feb 14, 2022

BUY
$59.5 - $67.25 $57,715 - $65,232
970 Added 444.95%
1,188 $78,000
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $1,625 - $2,032
27 Added 14.14%
218 $14,000
Q2 2021

Aug 13, 2021

BUY
$62.12 - $74.2 $11,864 - $14,172
191 New
191 $14,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.51B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.